Pharmacology

OnabotulinumtoxinA for Bladder Problems; Older Cancer Patients Not Getting Full Treatment; Vitamin B Reduces Diabetic Neuropathy

OnabotulinumtoxinA is thought of mostly as a treatment for facial wrinkles, but it's also approved for other medical conditions, including cervical dystonia; chronic migraine; and now, overactive bladder (OAB), a condition in which the bladder squeezes too often or without warning. OnabotulinumtoxinA, injected into the bladder, blocks the transmission of nerve impulses to the bladder muscle, calming contractions, which helps increase the bladder's storage capacity. It also reduces episodes of urinary incontinence.


 

Recommended Reading

Three Glargine Studies Find No Link to Cancer
Type 2 Diabetes ICYMI
Radiation to Pancreas Linked with Diabetes in Childhood Cancer Survivors
Type 2 Diabetes ICYMI
Another Study Finds No Glargine, Breast Cancer Link
Type 2 Diabetes ICYMI
Diabetes confers 27% increase in breast cancer risk
Type 2 Diabetes ICYMI
Smoking ups mortality threefold
Type 2 Diabetes ICYMI
Obesity, diabetes fuel liver disease epidemic
Type 2 Diabetes ICYMI
"Hemorrhoids" turn out to be cancer … and more
Type 2 Diabetes ICYMI
Diabetes May Increase Risk of Cancer Death
Type 2 Diabetes ICYMI
Evaluation of Vitamin D Supplementation in a Veteran Population
Type 2 Diabetes ICYMI
Vitamin D Deficiency
Type 2 Diabetes ICYMI